作者校正:"使用纵向修改治疗策略在竞争风险下的因果生存分析"
Iván Díaz1, Nicholas Williams2, Katherine L Hoffman3
1Division of Biostatistics, Department of Population Health, New York University Grossman School of Medicine, New York, USA. ivan.diaz@nyu.edu.
Lifetime data analysis
|April 14, 2025
概括
这项研究纠正了先前关于纵向修改治疗策略 (LMTPs) 的手稿中的错误. 修正后的方法将LMTP扩展到具有竞争风险的时间到事件数据,改善了纵向研究中的因果推断.
科学领域:
- 因果推理的原因推理.
- 纵向数据分析的数据分析.
- 具有竞争风险的生存分析.
背景情况:
- 发表的手稿包含了结果和对象定义中的错误,影响了纵向修改治疗政策 (LMTP) 分析.
- 纵向修改治疗策略 (LMTP) 是一种新的方法,用于定义和估计与纵向研究中的治疗自然价值相关的因果参数.
- 随着时间的推移,LMTPs可以对多种治疗方法的联合效应进行非参数定义和估计.
研究的目的:
- 纠正LMTPs上先前发表的手稿中的错误.
- 将LMTP方法扩展到具有竞争风险的时间到事件结果.
- 在复杂的纵向设置中提供识别结果和可靠的,数据适应的因果推理估计器.
主要方法:
- 纠正原稿定义中的错误. 原稿定义中的错误.
- 扩展LMTP方法论,以处理与竞争事件的时间到事件数据.
- 开发非参数,局部高效和数据适应的估计器,以最大限度地减少模型错误规范偏差.
主要成果:
- 修正后的手稿提供了一个强大的框架,用于在存在竞争风险的情况下使用LMTP进行因果推理.
- 提出的估计器是-consistent,并使用灵活的回归技术.
- 在估计COVID-19患者急性损伤上输入时间的影响方面有明显的应用,将死亡作为一个竞争事件.
结论:
- 扩展的LMTP方法为纵向研究中的因果推理提供了强大的工具,具有时间到事件结果和竞争风险.
- 数据适应式估计器通过减轻模型错误规范,提高了可靠性.
- 这项工作完善了复杂健康结果的因果推理技术,以COVID-19患者分析为例.
相关概念视频
Comparing the Survival Analysis of Two or More Groups
90
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
90
Assumptions of Survival Analysis
69
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
69
Introduction To Survival Analysis
124
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
124
Censoring Survival Data
47
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
47
Actuarial Approach
42
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
42
Cancer Survival Analysis
303
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
303


